{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:39:04Z","timestamp":1791135544059,"version":"4.1.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/ftd.0b013e318186e08e","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T03:10:01Z","timestamp":1223435401000},"page":"611-619","source":"Crossref","is-referenced-by-count":36,"title":["Studies on Antiretroviral Drug Concentrations in Breast Milk: Validation of a Liquid Chromatography-Tandem Mass Spectrometric Method for the Determination of 7 Anti-Human Immunodeficiency Virus Medications"],"prefix":"10.1097","volume":"30","author":[{"given":"Naser L","family":"Rezk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene S","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F","family":"Abdel-Megeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said S","family":"Moselhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D M","family":"Kashuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reducing the risk of maternal-infant transmission of HIV: a door is opened.","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1086\/420834","article-title":"2. The Breastfeeding and HIV International Transmission Study Group, Coutsoudis A, Dabis F, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis.","volume":"189","year":"2004","journal-title":"J Infect Dis"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.283.9.1175","article-title":"Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.","volume":"283","author":"De Cock","year":"2000","journal-title":"JAMA"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/jama.296.7.794","article-title":"Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.","volume":"296","author":"Thior","year":"2006","journal-title":"JAMA"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0731-7085(96)01880-8","article-title":"Analytical considerations for trace determinations of drugs in breast milk.","volume":"15","author":"Rossi","year":"1997","journal-title":"J Pharm Biomed Anal"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/bmc.865","article-title":"Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry.","volume":"21","author":"Jung","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/FTD.0b013e318074db39","article-title":"Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk.","volume":"29","author":"Rezk","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation: a revisit with a decade of progress.","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm Res"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/01.ftd.0000179844.45589.c7","article-title":"High-performance liquid chromatography-mass spectrometry in the clinical laboratory.","volume":"27","author":"Taylor","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1570-0232(03)00224-1","article-title":"13. Rezk NL, Tidwell RR, Kashuba AD. Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection.","volume":"791","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R14-10-20210129","first-page":"654","article-title":"Comment on the content and composition of lipids in infant formulas.","volume":"69","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0025-7125(16)30659-9","article-title":"Breastfeeding, and medical disease.","volume":"73","author":"Lawrence","year":"1989","journal-title":"Med Clin North Am"},{"key":"R16-10-20210129","first-page":"217","article-title":"16. Rezk NL, Rustin D, Kashuba AD. Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring.","volume":"28","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1373\/49.7.1041","article-title":"Ion suppression in mass spectrometry.","volume":"49","author":"Annesley","year":"2003","journal-title":"Clin Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e318186e08e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:13:23Z","timestamp":1786036403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200810000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318186e08e","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}